JP2017008114A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017008114A5 JP2017008114A5 JP2016203842A JP2016203842A JP2017008114A5 JP 2017008114 A5 JP2017008114 A5 JP 2017008114A5 JP 2016203842 A JP2016203842 A JP 2016203842A JP 2016203842 A JP2016203842 A JP 2016203842A JP 2017008114 A5 JP2017008114 A5 JP 2017008114A5
- Authority
- JP
- Japan
- Prior art keywords
- lipid
- aminoglycoside
- liposomal
- formulation
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940126575 aminoglycoside Drugs 0.000 claims 33
- 150000002632 lipids Chemical class 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 22
- 238000009472 formulation Methods 0.000 claims 21
- 239000000243 solution Substances 0.000 claims 11
- 150000003839 salts Chemical class 0.000 claims 10
- 239000007864 aqueous solution Substances 0.000 claims 8
- 239000003960 organic solvent Substances 0.000 claims 4
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 claims 3
- 239000000693 micelle Substances 0.000 claims 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 2
- 239000012267 brine Substances 0.000 claims 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims 2
- 238000007865 diluting Methods 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 150000003904 phospholipids Chemical class 0.000 claims 2
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 claims 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- 239000000725 suspension Substances 0.000 claims 2
- YWMSSKBMOFPBDM-UHFFFAOYSA-N 4-carbamoylbenzenesulfonyl chloride Chemical group NC(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 YWMSSKBMOFPBDM-UHFFFAOYSA-N 0.000 claims 1
- 229930182566 Gentamicin Natural products 0.000 claims 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 claims 1
- 229930182558 Sterol Natural products 0.000 claims 1
- 229960004821 amikacin Drugs 0.000 claims 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 claims 1
- 229960001656 amikacin sulfate Drugs 0.000 claims 1
- 235000012000 cholesterol Nutrition 0.000 claims 1
- 238000005354 coacervation Methods 0.000 claims 1
- 229960002518 gentamicin Drugs 0.000 claims 1
- 229960000318 kanamycin Drugs 0.000 claims 1
- 229930027917 kanamycin Natural products 0.000 claims 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims 1
- 229930182823 kanamycin A Natural products 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 229960000808 netilmicin Drugs 0.000 claims 1
- ZBGPYVZLYBDXKO-HILBYHGXSA-N netilmycin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@]([C@H](NC)[C@@H](O)CO1)(C)O)NCC)[C@H]1OC(CN)=CC[C@H]1N ZBGPYVZLYBDXKO-HILBYHGXSA-N 0.000 claims 1
- 239000011833 salt mixture Substances 0.000 claims 1
- 150000003432 sterols Chemical class 0.000 claims 1
- 235000003702 sterols Nutrition 0.000 claims 1
- 229960005322 streptomycin Drugs 0.000 claims 1
- 229960000707 tobramycin Drugs 0.000 claims 1
- NLVFBUXFDBBNBW-PBSUHMDJSA-N tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 claims 1
- 238000003260 vortexing Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78968806P | 2006-04-06 | 2006-04-06 | |
| US60/789,688 | 2006-04-06 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014165736A Division JP6088469B2 (ja) | 2006-04-06 | 2014-08-18 | コアセルベート化誘導リポソーム被包法及びその調合物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018000447A Division JP2018048212A (ja) | 2006-04-06 | 2018-01-05 | コアセルベート化誘導リポソーム被包法及びその調合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017008114A JP2017008114A (ja) | 2017-01-12 |
| JP2017008114A5 true JP2017008114A5 (enExample) | 2017-03-23 |
Family
ID=38581622
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504301A Active JP5600432B2 (ja) | 2006-04-06 | 2007-04-04 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2014093375A Pending JP2014139248A (ja) | 2006-04-06 | 2014-04-30 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2014165736A Active JP6088469B2 (ja) | 2006-04-06 | 2014-08-18 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2016203842A Pending JP2017008114A (ja) | 2006-04-06 | 2016-10-17 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2018000447A Pending JP2018048212A (ja) | 2006-04-06 | 2018-01-05 | コアセルベート化誘導リポソーム被包法及びその調合物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504301A Active JP5600432B2 (ja) | 2006-04-06 | 2007-04-04 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2014093375A Pending JP2014139248A (ja) | 2006-04-06 | 2014-04-30 | コアセルベート化誘導リポソーム被包法及びその調合物 |
| JP2014165736A Active JP6088469B2 (ja) | 2006-04-06 | 2014-08-18 | コアセルベート化誘導リポソーム被包法及びその調合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018000447A Pending JP2018048212A (ja) | 2006-04-06 | 2018-01-05 | コアセルベート化誘導リポソーム被包法及びその調合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20080089927A1 (enExample) |
| EP (2) | EP2012750B1 (enExample) |
| JP (5) | JP5600432B2 (enExample) |
| ES (1) | ES2668554T3 (enExample) |
| WO (1) | WO2007117550A2 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7718189B2 (en) | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| ES2439727T3 (es) * | 2002-10-29 | 2014-01-24 | Insmed Incorporated | Liberación sostenida de antiinfectantes |
| US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| JP4394916B2 (ja) * | 2003-09-19 | 2010-01-06 | 独立行政法人科学技術振興機構 | 人工脂質二重膜の形成装置および人工脂質二重膜の形成方法、並びにその利用 |
| AU2006322076C1 (en) | 2005-12-08 | 2013-11-14 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
| US20100196455A1 (en) * | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
| US9333214B2 (en) | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
| US9119783B2 (en) | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| US9114081B2 (en) | 2007-05-07 | 2015-08-25 | Insmed Incorporated | Methods of treating pulmonary disorders with liposomal amikacin formulations |
| ITRM20070681A1 (it) * | 2007-12-28 | 2009-06-29 | Carlo Tascini | Composizione liposomiale di colistina per uso terapeutico endovenoso orale e cutaneo |
| BRPI0923001A2 (pt) * | 2008-12-17 | 2018-09-18 | Oncothyreon Inc | método de produção de lipossomas pequenos |
| MX369828B (es) | 2012-05-21 | 2019-11-22 | Insmed Inc | Sistemas para tratar infecciones pulmonares. |
| ES2743039T3 (es) | 2012-11-29 | 2020-02-18 | Insmed Inc | Formulaciones de vancomicina estabilizada |
| US9603799B2 (en) * | 2013-03-15 | 2017-03-28 | Htd Biosystems Inc. | Liposomal vaccine adjuvants and methods of making and using same |
| US20160175553A1 (en) | 2013-07-17 | 2016-06-23 | Insmed Incorporated | Low resistance aerosol exhalation filter |
| EP3466432B1 (en) | 2014-05-15 | 2020-07-08 | Insmed Incorporated | Methods for treating pulmonary non-tuberculous mycobacterial infections |
| WO2019191627A1 (en) | 2018-03-30 | 2019-10-03 | Insmed Incorporated | Methods for continuous manufacture of liposomal drug products |
| US20210113467A1 (en) * | 2018-05-02 | 2021-04-22 | Robert Worsham | Methods for the manufacture of liposomal drug formulations |
| CN116437929B (zh) * | 2020-07-02 | 2025-11-11 | 普渡研究基金会 | 抗微生物化合物的吸入制剂 |
| CN116035946B (zh) * | 2022-10-25 | 2025-07-25 | 上海美自无双生物科技有限公司 | 一种通过复合凝聚法制备神经酰胺细胞磷脂组合物的方法及应用 |
| WO2024249293A1 (en) * | 2023-05-26 | 2024-12-05 | The Curators Of The University Of Missouri | Controlled release of therapeutic proteins for immunomodulation |
Family Cites Families (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4547490A (en) * | 1981-12-31 | 1985-10-15 | Neomed, Inc. | Synthetic whole blood and a method of making the same |
| US4606939A (en) * | 1983-06-22 | 1986-08-19 | The Ohio State University Research Foundation | Small particle formation |
| US4963367A (en) * | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
| US4794000A (en) * | 1987-01-08 | 1988-12-27 | Synthetic Blood Corporation | Coacervate-based oral delivery system for medically useful compositions |
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US5736155A (en) | 1984-08-08 | 1998-04-07 | The Liposome Company, Inc. | Encapsulation of antineoplastic agents in liposomes |
| IL91664A (en) | 1988-09-28 | 1993-05-13 | Yissum Res Dev Co | Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release |
| IT1245761B (it) * | 1991-01-30 | 1994-10-14 | Alfa Wassermann Spa | Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale. |
| EP0707472B1 (en) * | 1993-07-08 | 2001-03-14 | The Liposome Company, Inc. | Method of controlling the size of liposomes |
| JPH09506866A (ja) * | 1993-12-14 | 1997-07-08 | ジョーンズ ホプキンス ユニバーシティー スクール オブ メディシン | 医薬として活性のある物質の免疫療法のための放出制御 |
| US5508269A (en) * | 1994-10-19 | 1996-04-16 | Pathogenesis Corporation | Aminoglycoside formulation for aerosolization |
| US5800833A (en) | 1995-02-27 | 1998-09-01 | University Of British Columbia | Method for loading lipid vesicles |
| US5840702A (en) * | 1996-03-22 | 1998-11-24 | Uab Research Foundation | Cystic fibrosis treatment |
| US6503881B2 (en) * | 1996-08-21 | 2003-01-07 | Micrologix Biotech Inc. | Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| US5837282A (en) | 1996-10-30 | 1998-11-17 | University Of British Columbia | Ionophore-mediated liposome loading |
| DK1024814T3 (da) * | 1997-10-22 | 2008-01-02 | Jens Ponikau | Anvendelse af antisvampemidler til topisk behandling af svampe-induceret mucositis |
| US6916490B1 (en) * | 1998-07-23 | 2005-07-12 | UAB Research Center | Controlled release of bioactive substances |
| US6855296B1 (en) * | 1998-11-13 | 2005-02-15 | Optime Therapeutics, Inc. | Method and apparatus for liposome production |
| SI20959A (sl) * | 1998-12-17 | 2003-02-28 | Pathogenesis Corporation | Metoda za zdravljenje hudega kroničnega bronhitisa (bronhiektazije) z aerosoliziranimi antibiotiki |
| AU773515B2 (en) * | 1999-02-08 | 2004-05-27 | Alza Corporation | Method for controlling liposome size |
| AU771706B2 (en) * | 1999-07-15 | 2004-04-01 | University Of British Columbia, The | Methods and apparatus for preparation of lipid vesicles |
| US6962151B1 (en) * | 1999-11-05 | 2005-11-08 | Pari GmbH Spezialisten für effektive Inhalation | Inhalation nebulizer |
| ATE341310T1 (de) * | 2000-02-04 | 2006-10-15 | Lipoxen Technologies Ltd | Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome |
| US7600511B2 (en) * | 2001-11-01 | 2009-10-13 | Novartis Pharma Ag | Apparatus and methods for delivery of medicament to a respiratory system |
| MXPA02010884A (es) * | 2000-05-05 | 2003-03-27 | Aerogen Ireland Ltd | Aparato y metodo para el suministro de medicamentos al sistema respiratorio. |
| US6948491B2 (en) * | 2001-03-20 | 2005-09-27 | Aerogen, Inc. | Convertible fluid feed system with comformable reservoir and methods |
| US7971588B2 (en) * | 2000-05-05 | 2011-07-05 | Novartis Ag | Methods and systems for operating an aerosol generator |
| US8336545B2 (en) * | 2000-05-05 | 2012-12-25 | Novartis Pharma Ag | Methods and systems for operating an aerosol generator |
| US7100600B2 (en) * | 2001-03-20 | 2006-09-05 | Aerogen, Inc. | Fluid filled ampoules and methods for their use in aerosolizers |
| EP1203614A1 (de) * | 2000-11-03 | 2002-05-08 | Polymun Scientific Immunbiologische Forschung GmbH | Verfahren und Vorrichtung zur Herstellung von Lipidvesikeln |
| DE10109897A1 (de) * | 2001-02-21 | 2002-11-07 | Novosom Ag | Fakultativ kationische Liposomen und Verwendung dieser |
| WO2003053411A1 (en) * | 2001-12-19 | 2003-07-03 | Nektar Therapeutics | Pulmonary delivery of aminoglycosides |
| EP1474196B1 (en) * | 2002-01-15 | 2016-08-17 | Novartis AG | Methods and systems for operating an aerosol generator |
| WO2003075889A1 (en) * | 2002-03-05 | 2003-09-18 | Transave, Inc. | An inhalation system for prevention and treatment of intracellular infections |
| US7901708B2 (en) * | 2002-06-28 | 2011-03-08 | Protiva Biotherapeutics, Inc. | Liposomal apparatus and manufacturing methods |
| KR100489701B1 (ko) * | 2002-10-09 | 2005-05-16 | 주식회사 태평양 | 고농도의 트리터페노이드를 함유하는 미소화 리포좀 및 그제조방법 |
| ES2439727T3 (es) | 2002-10-29 | 2014-01-24 | Insmed Incorporated | Liberación sostenida de antiinfectantes |
| US7879351B2 (en) * | 2002-10-29 | 2011-02-01 | Transave, Inc. | High delivery rates for lipid based drug formulations, and methods of treatment thereof |
| US7718189B2 (en) * | 2002-10-29 | 2010-05-18 | Transave, Inc. | Sustained release of antiinfectives |
| US7968115B2 (en) * | 2004-03-05 | 2011-06-28 | Board Of Regents, The University Of Texas System | Liposomal curcumin for treatment of cancer |
| GB2388581A (en) * | 2003-08-22 | 2003-11-19 | Danisco | Coated aqueous beads |
| US7556799B2 (en) * | 2004-03-30 | 2009-07-07 | Relypsa, Inc. | Ion binding polymers and uses thereof |
| JP4452799B2 (ja) * | 2004-07-14 | 2010-04-21 | 独立行政法人産業技術総合研究所 | コアセルベートを活用したリポソームの製造方法 |
| JP2006077843A (ja) * | 2004-09-08 | 2006-03-23 | Aichi Mach Ind Co Ltd | 軸部材の支持構造 |
| JP2006263054A (ja) * | 2005-03-23 | 2006-10-05 | Konica Minolta Sensing Inc | 呼吸器系疾患関連解析データの取得方法、オキシメータシステム及びその動作プログラム、オキシメータ並びに酸素補給システム |
| JP5639338B2 (ja) * | 2005-07-27 | 2014-12-10 | プロチバ バイオセラピューティクス インコーポレイティッド | リポソームの製造システムおよび製造方法 |
| KR100705981B1 (ko) * | 2005-10-12 | 2007-04-10 | 주식회사 리제론 | 인간 성장호르몬을 포함하는 탈모방지 또는 발모촉진용조성물 |
| AU2006322076C1 (en) * | 2005-12-08 | 2013-11-14 | Insmed Incorporated | Lipid-based compositions of antiinfectives for treating pulmonary infections |
| US8268347B1 (en) * | 2006-10-24 | 2012-09-18 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US8119156B2 (en) * | 2006-10-24 | 2012-02-21 | Aradigm Corporation | Dual action, inhaled formulations providing both an immediate and sustained release profile |
| US20100196455A1 (en) * | 2007-05-04 | 2010-08-05 | Transave, Inc. | Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
| US9333214B2 (en) * | 2007-05-07 | 2016-05-10 | Insmed Incorporated | Method for treating pulmonary disorders with liposomal amikacin formulations |
| US9119783B2 (en) * | 2007-05-07 | 2015-09-01 | Insmed Incorporated | Method of treating pulmonary disorders with liposomal amikacin formulations |
| WO2009037970A1 (ja) * | 2007-09-21 | 2009-03-26 | Murata Manufacturing Co., Ltd. | 落下検知装置、磁気ディスク装置および携帯電子機器 |
| WO2012007130A1 (en) * | 2010-07-12 | 2012-01-19 | Xellia Pharmaceuticals Aps | Treatment of lung infections by administration of tobramycin by aerolisation |
| MX369828B (es) * | 2012-05-21 | 2019-11-22 | Insmed Inc | Sistemas para tratar infecciones pulmonares. |
-
2007
- 2007-04-04 EP EP07754936.8A patent/EP2012750B1/en active Active
- 2007-04-04 ES ES07754936.8T patent/ES2668554T3/es active Active
- 2007-04-04 JP JP2009504301A patent/JP5600432B2/ja active Active
- 2007-04-04 US US11/696,343 patent/US20080089927A1/en not_active Abandoned
- 2007-04-04 EP EP17207115.1A patent/EP3354260B1/en active Active
- 2007-04-04 WO PCT/US2007/008500 patent/WO2007117550A2/en not_active Ceased
-
2014
- 2014-04-30 JP JP2014093375A patent/JP2014139248A/ja active Pending
- 2014-08-18 JP JP2014165736A patent/JP6088469B2/ja active Active
-
2016
- 2016-10-17 JP JP2016203842A patent/JP2017008114A/ja active Pending
-
2018
- 2018-01-05 JP JP2018000447A patent/JP2018048212A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017008114A5 (enExample) | ||
| JP2528153B2 (ja) | リポソ―ム製剤および抗生物質 | |
| ME02518B (me) | Smeša lipozoma | |
| HRP20230063T1 (hr) | Spoj i pripravci za intracelularnu isporuku terapijskih sredstava | |
| JP2009528340A5 (enExample) | ||
| JP2016529284A5 (enExample) | ||
| JP2018507227A (ja) | 二薬搭載リポソーム医薬製剤 | |
| JP6893245B2 (ja) | 脂質ナノ粒子用膜材料組成物 | |
| JPH08508046A (ja) | タキソール製剤 | |
| JP2014513135A5 (enExample) | ||
| CN103893123A (zh) | 一种脂质体-聚合物杂化纳米粒子及其制备方法和应用 | |
| Debnath et al. | Structural and functional significance of niosome and proniosome in drug delivery system | |
| WO2014022414A1 (en) | Cochleates made with soy phosphatidylserine | |
| PL226015B1 (pl) | Liposomowy preparat zawierajacy przeciwnowotworowa substancje aktywna, sposob jego wytwarzania i zawierajaca go kompozycja farmaceutyczna | |
| CN101579314A (zh) | 有机-无机复合脂质体的抗癌药物缓释制剂及其制备方法 | |
| JP2024075590A (ja) | リポソーム薬物製剤の製造方法 | |
| CN103082031A (zh) | 一种鱼油纳米脂质体的制备方法 | |
| CN113384530A (zh) | 一种多糖核心Nanocells及其制备方法与应用 | |
| CN101804028A (zh) | 一种中药脂质体的制备方法 | |
| JP2008542402A5 (enExample) | ||
| TWI249408B (en) | New antifungal formulation and manufacturing method thereof | |
| JP6322733B2 (ja) | 親水性領域において正の全電荷を示す両親媒性分子種aおよび両親媒性分子種bおよびポリフェノールcを含む分子混合物、該分子混合物の製造方法、ならびにその使用 | |
| CN105534905A (zh) | 一种含有恩替卡韦的多囊脂质体及其制备方法 | |
| TWI459967B (zh) | 人造油體及其製造方法 | |
| CN109077997B (zh) | 培美曲塞二钠脂质复合物及其制备方法 |